Medication info
Terbinafine Tablets (Terbinafine Hydrochloride)

Terbinafine Tablets (Terbinafine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
SS Pharm Co., Ltd.
Appearance
White, round tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200403309 · Approved 2004.03.31 · Insurance code 652604050

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis in children
Who takes it
Adults · Children
Adult dose
Adults Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. Infections of the fingernails or relatively small toenails, or in younger patients, may require a shorter treatment period of 3 months or less. Treatment of toenail infections usually requires 3 months, but some patients may need 6 months or longer. Treatment may take longer in patients with slow nail growth. 3. Patients with renal impairment Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL/min.
Child dose
Administer to children aged 2 years and older. Use is not recommended in children younger than 2 years because there is no experience with its use in this age group. Tinea capitis: 4 weeks To prevent recurrence of infection, treatment should be given regularly for an appropriate, specified duration. Body weight below 20 kg (younger than 5 years): Administer 62.5 mg once daily. As experience with treatment is limited, decide whether to administer after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight above 40 kg (older than 12 years): Administer 250 mg once daily.

Ingredients

Manufacturer
SS Pharm Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis in children

  • Skin fungal infections
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used for the treatment of tinea pedis, tinea corporis, tinea cruris, onychomycosis in adults, and tinea capitis in children caused by dermatophytes.

How to take

Adult dose

Adults Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. Infections of the fingernails or relatively small toenails, or in younger patients, may require a shorter treatment period of 3 months or less. Treatment of toenail infections usually requires 3 months, but some patients may need 6 months or longer. Treatment may take longer in patients with slow nail growth. 3. Patients with renal impairment Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL/min.

Child dose

Administer to children aged 2 years and older. Use is not recommended in children younger than 2 years because there is no experience with its use in this age group. Tinea capitis: 4 weeks To prevent recurrence of infection, treatment should be given regularly for an appropriate, specified duration. Body weight below 20 kg (younger than 5 years): Administer 62.5 mg once daily. As experience with treatment is limited, decide whether to administer after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight above 40 kg (older than 12 years): Administer 250 mg once daily.

Precautions

This medication is not recommended for patients with liver problems or a history of liver disease. Regular liver function tests should be performed before and during treatment, and if any signs of liver dysfunction occur, the medication should be discontinued immediately and a doctor consulted. This medication can have a serious impact on liver function and poses a risk of liver failure, so caution is needed. Patients with allergies to this medication, specific blood disorders, severe renal impairment, children under 2 years old, and nursing women should not use it. Patients with certain genetic disorders like lactose intolerance should also not take this medication. Use in patients with weak kidney function, elderly patients, and children weighing less than 20 kg should be done cautiously, and if severe skin reactions occur, the medication should be stopped immediately. This medication should also be used with caution in patients with skin diseases or systemic lupus erythematosus. During treatment, various side effects like rash, itching, nausea, fatigue, muscle pain, headache, visual disturbances may occur, so any unusual symptoms should be reported to a doctor. Care should be taken when driving or operating machinery if dizziness occurs. Interactions may occur when taken with other drugs, so inform your doctor if you are taking any other medications. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and nursing mothers should discontinue breastfeeding. Children and elderly patients should be particularly careful and monitor their physical condition closely while taking this medication. In case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur, and immediate medical attention is required. This medication should be kept out of reach of children and stored at room temperature away from direct sunlight.

Side effects

Hepatic and biliary insufficiency, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, increased γ-GTP, increased AST/ALT, increased LDH, increased ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasis-like rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, increased CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, paresthesia, sensory impairment, decreased attention, insomnia, increased BUN, polyuria, visual disturbances, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, increased total cholesterol in the blood, increased triglycerides, fatigue, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reactions, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended to maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White, round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.